JPRN-UMIN000030346
Completed
未知
Study of the usefulness of neoadjuvant chemo-hormone therapy for high-risk prostate cancer - Neoadjuvant chemo-hormone therapy for high-risk prostate cancer
ConditionsProstate cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Prostate cancer
- Sponsor
- Fujita Health University Hospital
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Patients who receiving hormonal therapy. 2\. AST/ALT more than 100 IU/L by screening. 3\. Patients who are judged inteligible for entry to this study principal investigator or sub\-investigator.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Investigation of neoadjuvant chemohormonal therapy before robot-assisted radical prostatectomy for the patients with high-risk prostate cancer.JPRN-UMIN000034906Tottori University Hospital100
Recruiting
Phase 2
Investigation of neoadjuvant chemohormonal therapy before robot-assisted radical prostatectomy for the patients with high-risk prostate cancer.JPRN-jRCTs061180057Takenaka Atsushi100
Completed
Phase 2
Effect of preoperative chemotherapy in the treatment of patients with locally advanced rectal cancerRectal cancer.Malignant neoplasm of rectumIRCT2016082129403N2Vice chancellor for research, Shiraz University of Medical Sciences40
Recruiting
Not Applicable
The efficacy and safety of neoadjuvant chemohormonal therapy followed by robot-assisted radical prostatectomy and/or radiation therapy for prostate cancer patients with oligometastasis: A prospective multicenter studyProstate cancerJPRN-UMIN000046528Gifu University30
Recruiting
Phase 2
eoadjuvant chemotherapy in NSCLCHealth Condition 1: C349- Malignant neoplasm of unspecifiedpart of bronchus or lungHealth Condition 2: null- stage 2b and 3 Non Small Cell Lung CancerCTRI/2016/05/006916investigator initiated study